The characteristics and in vivo suppression of neointimal formation with sirolimus-eluting polymeric stents

Mei-Chin Chen, Yen Chang, Chin Tang Liu, Wei Yun Lai, Shu Fen Peng, Yi Wen Hung, Hung Wen Tsai, Hsing Wen Sung

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Drug-eluting stents have emerged as a predominant percutaneous strategy in patients with coronary artery disease. However, hypersensitivity reactions caused by their nonerodable polymer coatings and bare-metal stents may result in serious clinical sequelae. In this report, a new biodegradable sirolimus-eluting stent, made from chitosan-based strips fixed by an epoxy compound, coated with a hydrophobic heparin was developed. Due to the covalent crosslinks formed in the stent matrix, the fabricated stent had a shape-memory property to memorize its permanent shape. The shape-memory ability and mechanical strength of the stent could be enhanced by increasing its degree of crosslinking. The cytocompatibility of the stent was demonstrated in vitro. The heparin coating on the stent effectively reduced platelet adhesion; additionally, it acted as a diffusion barrier and led to a nearly linear sustained-release profile of sirolimus. Cell-cycle analysis demonstrated that the released sirolimus could inhibit smooth muscle cell proliferation by inducing cell-cycle arrest in G1 phase. When compared to the unloaded stent, neointimal formation was significantly suppressed after implantation of the sirolimus-eluting stent in rabbit infrarenal abdominal aortas. These findings suggested that the developed sirolimus-eluting polymeric stent can be a potential alternative for treatment of atherosclerosis.

Original languageEnglish
Pages (from-to)79-88
Number of pages10
JournalBiomaterials
Volume30
Issue number1
DOIs
Publication statusPublished - 2009 Jan 1

Fingerprint

Stents
Sirolimus
Shape memory effect
Heparin
Cells
Drug-Eluting Stents
Coatings
Epoxy Compounds
Abdominal Aorta
Chitosan
G1 Phase
Diffusion barriers
Cell Cycle Checkpoints
Cell proliferation
Platelets
Smooth Muscle Myocytes
Coronary Artery Disease
Crosslinking
Atherosclerosis
Cell Cycle

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Cite this

Chen, Mei-Chin ; Chang, Yen ; Liu, Chin Tang ; Lai, Wei Yun ; Peng, Shu Fen ; Hung, Yi Wen ; Tsai, Hung Wen ; Sung, Hsing Wen. / The characteristics and in vivo suppression of neointimal formation with sirolimus-eluting polymeric stents. In: Biomaterials. 2009 ; Vol. 30, No. 1. pp. 79-88.
@article{c6cf25e934f64325b2443de57b82218e,
title = "The characteristics and in vivo suppression of neointimal formation with sirolimus-eluting polymeric stents",
abstract = "Drug-eluting stents have emerged as a predominant percutaneous strategy in patients with coronary artery disease. However, hypersensitivity reactions caused by their nonerodable polymer coatings and bare-metal stents may result in serious clinical sequelae. In this report, a new biodegradable sirolimus-eluting stent, made from chitosan-based strips fixed by an epoxy compound, coated with a hydrophobic heparin was developed. Due to the covalent crosslinks formed in the stent matrix, the fabricated stent had a shape-memory property to memorize its permanent shape. The shape-memory ability and mechanical strength of the stent could be enhanced by increasing its degree of crosslinking. The cytocompatibility of the stent was demonstrated in vitro. The heparin coating on the stent effectively reduced platelet adhesion; additionally, it acted as a diffusion barrier and led to a nearly linear sustained-release profile of sirolimus. Cell-cycle analysis demonstrated that the released sirolimus could inhibit smooth muscle cell proliferation by inducing cell-cycle arrest in G1 phase. When compared to the unloaded stent, neointimal formation was significantly suppressed after implantation of the sirolimus-eluting stent in rabbit infrarenal abdominal aortas. These findings suggested that the developed sirolimus-eluting polymeric stent can be a potential alternative for treatment of atherosclerosis.",
author = "Mei-Chin Chen and Yen Chang and Liu, {Chin Tang} and Lai, {Wei Yun} and Peng, {Shu Fen} and Hung, {Yi Wen} and Tsai, {Hung Wen} and Sung, {Hsing Wen}",
year = "2009",
month = "1",
day = "1",
doi = "10.1016/j.biomaterials.2008.09.006",
language = "English",
volume = "30",
pages = "79--88",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "1",

}

The characteristics and in vivo suppression of neointimal formation with sirolimus-eluting polymeric stents. / Chen, Mei-Chin; Chang, Yen; Liu, Chin Tang; Lai, Wei Yun; Peng, Shu Fen; Hung, Yi Wen; Tsai, Hung Wen; Sung, Hsing Wen.

In: Biomaterials, Vol. 30, No. 1, 01.01.2009, p. 79-88.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The characteristics and in vivo suppression of neointimal formation with sirolimus-eluting polymeric stents

AU - Chen, Mei-Chin

AU - Chang, Yen

AU - Liu, Chin Tang

AU - Lai, Wei Yun

AU - Peng, Shu Fen

AU - Hung, Yi Wen

AU - Tsai, Hung Wen

AU - Sung, Hsing Wen

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Drug-eluting stents have emerged as a predominant percutaneous strategy in patients with coronary artery disease. However, hypersensitivity reactions caused by their nonerodable polymer coatings and bare-metal stents may result in serious clinical sequelae. In this report, a new biodegradable sirolimus-eluting stent, made from chitosan-based strips fixed by an epoxy compound, coated with a hydrophobic heparin was developed. Due to the covalent crosslinks formed in the stent matrix, the fabricated stent had a shape-memory property to memorize its permanent shape. The shape-memory ability and mechanical strength of the stent could be enhanced by increasing its degree of crosslinking. The cytocompatibility of the stent was demonstrated in vitro. The heparin coating on the stent effectively reduced platelet adhesion; additionally, it acted as a diffusion barrier and led to a nearly linear sustained-release profile of sirolimus. Cell-cycle analysis demonstrated that the released sirolimus could inhibit smooth muscle cell proliferation by inducing cell-cycle arrest in G1 phase. When compared to the unloaded stent, neointimal formation was significantly suppressed after implantation of the sirolimus-eluting stent in rabbit infrarenal abdominal aortas. These findings suggested that the developed sirolimus-eluting polymeric stent can be a potential alternative for treatment of atherosclerosis.

AB - Drug-eluting stents have emerged as a predominant percutaneous strategy in patients with coronary artery disease. However, hypersensitivity reactions caused by their nonerodable polymer coatings and bare-metal stents may result in serious clinical sequelae. In this report, a new biodegradable sirolimus-eluting stent, made from chitosan-based strips fixed by an epoxy compound, coated with a hydrophobic heparin was developed. Due to the covalent crosslinks formed in the stent matrix, the fabricated stent had a shape-memory property to memorize its permanent shape. The shape-memory ability and mechanical strength of the stent could be enhanced by increasing its degree of crosslinking. The cytocompatibility of the stent was demonstrated in vitro. The heparin coating on the stent effectively reduced platelet adhesion; additionally, it acted as a diffusion barrier and led to a nearly linear sustained-release profile of sirolimus. Cell-cycle analysis demonstrated that the released sirolimus could inhibit smooth muscle cell proliferation by inducing cell-cycle arrest in G1 phase. When compared to the unloaded stent, neointimal formation was significantly suppressed after implantation of the sirolimus-eluting stent in rabbit infrarenal abdominal aortas. These findings suggested that the developed sirolimus-eluting polymeric stent can be a potential alternative for treatment of atherosclerosis.

UR - http://www.scopus.com/inward/record.url?scp=53849145295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53849145295&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2008.09.006

DO - 10.1016/j.biomaterials.2008.09.006

M3 - Article

C2 - 18838155

AN - SCOPUS:53849145295

VL - 30

SP - 79

EP - 88

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 1

ER -